[go: up one dir, main page]

DK0893992T3 - Hurtigt sönderdelende oral doseringsform - Google Patents

Hurtigt sönderdelende oral doseringsform

Info

Publication number
DK0893992T3
DK0893992T3 DK97918112T DK97918112T DK0893992T3 DK 0893992 T3 DK0893992 T3 DK 0893992T3 DK 97918112 T DK97918112 T DK 97918112T DK 97918112 T DK97918112 T DK 97918112T DK 0893992 T3 DK0893992 T3 DK 0893992T3
Authority
DK
Denmark
Prior art keywords
dosage form
pct
date oct
oral dosage
sec
Prior art date
Application number
DK97918112T
Other languages
English (en)
Inventor
Pierre Humbert-Droz
Matthias Seidel
Rosa Martani
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of DK0893992T3 publication Critical patent/DK0893992T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97918112T 1996-04-16 1997-04-04 Hurtigt sönderdelende oral doseringsform DK0893992T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810236 1996-04-16
PCT/EP1997/001696 WO1997038679A2 (en) 1996-04-16 1997-04-04 Fast disintegrating oral dosage form

Publications (1)

Publication Number Publication Date
DK0893992T3 true DK0893992T3 (da) 2004-06-01

Family

ID=8225590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918112T DK0893992T3 (da) 1996-04-16 1997-04-04 Hurtigt sönderdelende oral doseringsform

Country Status (12)

Country Link
US (1) US6083531A (da)
EP (1) EP0893992B1 (da)
JP (1) JP2000508649A (da)
AT (1) ATE260646T1 (da)
AU (1) AU2636797A (da)
DE (1) DE69727922T2 (da)
DK (1) DK0893992T3 (da)
ES (1) ES2217410T3 (da)
PT (1) PT893992E (da)
TR (1) TR199802068T2 (da)
WO (1) WO1997038679A2 (da)
ZA (1) ZA973190B (da)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69901938T3 (de) * 1998-03-06 2012-08-02 Aptalis Pharma S.R.L. Schnell zerfallende tablette
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
HK1042856B (zh) * 1998-11-20 2007-07-27 Skyepharma Canada Inc. 可分散的磷脂稳定的微粒
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
JP2003506480A (ja) 1999-08-17 2003-02-18 ノバルテイス・コンシユーマー・ヘルス・エス・アー 急速に溶解する剤形およびその製造方法
CZ301813B6 (cs) * 2000-06-27 2010-06-30 F. Hoffmann-La Roche Ag Zpusob prípravy farmaceutické kompozice
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
IN192750B (da) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
US20030148818A1 (en) * 2002-01-18 2003-08-07 Myrhum Mark C. Golf club woods with wood club head having a selectable center of gravity and a selectable shaft
AU2003211051A1 (en) * 2002-02-13 2003-09-04 Michael K. Weibel Drug dose-form and method of manufacture
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
NZ545982A (en) * 2003-09-24 2009-09-25 Novartis Consumer Health Sa Coated tablets comprising diclofenac in the core
WO2005044006A1 (en) * 2003-11-05 2005-05-19 Battelle Memorial Institute Quick dissolving agrochemical products
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP5154924B2 (ja) * 2004-05-11 2013-02-27 エガレット エイ／エス ジェランガムを含む膨張可能な投与形態
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US7992575B2 (en) * 2005-02-28 2011-08-09 U.S. Smokeless Tobacco Company Use of chlorate, sulfur or ozone to reduce tobacco specific nitrosamines
IS7724A (is) 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
KR100702069B1 (ko) 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
CA2673458A1 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
ES2302650B1 (es) 2007-01-11 2009-02-16 Tedec-Meiji Farma, S.A. Composicion de rapida desintegracion en la cavidad bucal.
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
US9271524B1 (en) 2007-09-07 2016-03-01 U.S. Smokeless Tobacco Company Tobacco having reduced tobacco specific nitrosamine content
CA2704209C (en) 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Orally disintegrative dosage form
CA2716901C (en) * 2008-02-28 2018-07-03 R.P. Scherer Technologies, Llc Process to minimize polymorphism
EP2133071A1 (en) * 2008-06-09 2009-12-16 Université de la Méditerranée Process for making gastroretentive dosage forms
FR2933959B1 (fr) * 2008-07-16 2010-09-10 Roquette Freres Procede de fabrication de films directement en alveole.
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
EP2243469B1 (de) 2009-04-22 2012-06-27 Dr. Suwelack Skin & Health Care AG Gefriergetrockneter Formkörper enthaltend Magnesiumascorbylphosphat
MX2011012078A (es) * 2009-05-20 2012-03-14 Lingual Consegna Pty Ltd Formulacion terapeutica bucal y/o sublingual.
US8545879B2 (en) 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
WO2012039788A1 (en) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Multi-layered orally disintegrating tablet and the manufacture thereof
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
RU2013118252A (ru) * 2010-09-22 2014-10-27 МакНЕЙЛ-ППС, ИНК. Производство таблеток из порошковой смеси, обработанной излучением
BR112013006522A2 (pt) * 2010-09-22 2016-07-12 Mcneil Ppc Inc afbricação de formas de dosagem com densidade variável mediante o uso de energia de radiofrequência
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
WO2014007780A1 (en) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of dexketoprofen
WO2014007779A1 (en) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of dexketoprofen
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
EP3091966B1 (en) 2014-01-10 2019-07-31 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
DK3807260T3 (da) 2018-06-15 2024-10-14 Reynolds Tobacco Co R Oprensning af nikotin
CN116490194A (zh) * 2020-10-30 2023-07-25 帝斯曼知识产权资产管理有限公司 含hmo的非泡腾可溶性片剂
WO2022090111A1 (en) * 2020-10-30 2022-05-05 Dsm Ip Assets B.V. Non-effervescent dissolvable tablets comprising hmos

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
EP0491754A4 (en) * 1989-09-15 1992-08-12 Cima Labs, Inc. Magnesium carbonate and oil tableting aid
AU646232B2 (en) * 1989-10-02 1994-02-17 Cima Labs, Inc. Effervescent dosage form and method of administering same
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP2807346B2 (ja) * 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
EP0627218B1 (en) * 1992-02-18 2001-12-19 Nippon Shinyaku Company, Limited Process for producing fast soluble tablets and fast soluble tablets comprising xylitol
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
BR9506579A (pt) * 1994-01-27 1997-09-16 Univ Oklahoma Matriz de suporte particulado forma de dosagem farmacêutica sólida de rápida dissolução processo para a preparação da matriz de suporte particulado e processo para a preparação da forma de dosagem farmacêutica sólida de rápida dissolução
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
WO1997038679A3 (en) 1997-12-04
ES2217410T3 (es) 2004-11-01
ATE260646T1 (de) 2004-03-15
JP2000508649A (ja) 2000-07-11
EP0893992B1 (en) 2004-03-03
ZA973190B (en) 1997-12-17
EP0893992A2 (en) 1999-02-03
DE69727922T2 (de) 2005-01-20
AU2636797A (en) 1997-11-07
US6083531A (en) 2000-07-04
DE69727922D1 (de) 2004-04-08
HK1016492A1 (en) 1999-11-05
TR199802068T2 (xx) 2000-01-21
PT893992E (pt) 2004-06-30
WO1997038679A2 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
DK0893992T3 (da) Hurtigt sönderdelende oral doseringsform
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
RU2220723C2 (ru) Средство и способ лечения или профилактики артериосклероза
AU1537095A (en) Therapeutic agents containing thyroid hormones
ATE293458T1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
TR199802698T2 (xx) Valsartan�n kat� oral doz formlar�.
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
BG105534A (en) 5ht1 means and method for the treatment of migraine
IL108234A0 (en) Pharmaceutical composition containing galanthamine
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
EE03385B1 (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
PL348202A1 (en) Pharmaceutically active composition and dispensing device
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
GR3030954T3 (en) Children-proof package for active substance-containing plaster
GEP20043377B (en) Pharmaceutical Complex
SE9700868D0 (sv) Kalciumkomposition
MY127600A (en) Solid oral dosage forms of valsartan
ECSP972162A (es) Formas solidas de dosificacion oral que contienen valsartan